Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

Figure 3

Late effects in normal tissues subjective, objective, management, and analytic scales (LENT/SOMA) questionnaires data. Line graph showing median scores at baseline, 2-year and 7-year followup (bowel function, *baseline to 2 years 𝑃=0.015, ***baseline to 7 years, 𝑃<0.001; sexual function, **baseline to 2 years 𝑃<0.01; **2 years to 7 years 𝑃<0.01 (not shown), ***baseline to 7 years 𝑃<0.001).